Patent application number | Description | Published |
20110178879 | Relationship prediction system using external databases - A Relationship Prediction System Using External Databases for providing a relationship prediction based on the correlation of personal characteristics and the analysis of genetic characteristics is disclosed. In one embodiment, a first person supplies descriptions of their own personal characteristics, as well as descriptions of the personal characteristics of their ideal match, to a website. The first person also furnishes an odor, tissue or fluid sample to a test facility, where genetic characteristics are analyzed and determined. A relationship match is then generated based on both a combination of both a positive correlation of the personal characteristics of the first person and second person, and a measured dissimilarity between the sequence of genetic characteristics of the first person and second person. In one embodiment, personal characteristics are obtained from one or more external webpages. | 07-21-2011 |
20130090979 | Relationship prediction system using external databases - A Relationship Prediction System Using External Databases for providing a relationship prediction based on the correlation of personal characteristics and the analysis of genetic characteristics is disclosed. In one embodiment, a first person supplies descriptions of their own personal characteristics, as well as descriptions of the personal characteristics of their ideal match, to a website. The first person also furnishes an odor, tissue or fluid sample to a test facility, where genetic characteristics are analyzed and determined. A relationship match is then generated based on both a combination of both a positive correlation of the personal characteristics of the first person and second person, and a measured dissimilarity between the sequence of genetic characteristics of the first person and second person. In one embodiment, personal characteristics are obtained from one or more external webpages. | 04-11-2013 |
Patent application number | Description | Published |
20090018184 | Polyether Brevetoxin Derivatives as a Treatment for Cystic Fibrosis, Mucociliary Dysfunction, and Pulmonary Diseases - Disclosed are compounds that are derivatives of brevetoxin, or PbTx, pharmaceutical formulations comprising the compounds, and methods of regulating mucus transport in a cell, treating mucociliary dysfunction and diseases related to decreased mucus transport, wherein the compounds are of the Formula (I), and Formula (III): | 01-15-2009 |
20100099643 | Fused Pentacyclic Polyethers - Disclosed are polycyclic polyether compounds of formula I and pharmaceutical compositions comprising such compounds. | 04-22-2010 |
20110009479 | Stimulating Neuronal Growth Using Brevetoxins - Disclosed are methods of treating neurodegenerative diseases or disorders in a subject in need of such treatment. The methods comprise administering to a subject in need of such treatment a therapeutically effective amount of brevetoxin or brevetoxin derivatives. Included in the diseases and disorders are Alzheimer's Disease, Huntington's Disease, Parkinson's Disease, Multiple sclerosis (MS), Amyotrophic Lateral Sclerosis (ALS/Lou Gehrig's Disease) and other Motor Neuron Diseases, Prion Diseases, Frontotemporal Dementia (FTD), and CNS dysfunctions such as schizophrenia, depression, and epilepsy. Also included are neurodegenerations resulting from stroke, heart attack, head and spinal cord trauma, traumatic brain injury, bleeding in the brain and other injuries to the central nervous system (CNS). | 01-13-2011 |
20120122810 | Fused Pentacyclic Polyethers - Disclosed are polycyclic polyether compounds of formula I and pharmaceutical compositions comprising such compounds. | 05-17-2012 |
20140073604 | Ladder-Frame Polyether Conjugates - Disclosed are compounds that are conjugates of ladder frame polyether compounds and biologically active compounds or research compounds, pharmaceutical formulations comprising the conjugates, and methods of transporting the conjugates across biological membranes. | 03-13-2014 |
20140107060 | Fused Pentacyclic Polyethers - Disclosed are polycyclic polyether compounds of formula I and pharmaceutical compositions comprising such compounds. | 04-17-2014 |
Patent application number | Description | Published |
20080229056 | METHOD AND APPARATUS FOR DUAL-HASHING TABLES - Methods and apparatus for dual hash tables are disclosed. An example method includes logically dividing a hash table data structure into a first hash table and a second hash table, where the first hash table and the second hash table are substantially logically equivalent. The example method further includes receiving a key and a corresponding data value, applying a first hash function to the key to produce a first index to a first bucket in the first hash table, and applying a second hash function to the key to produce a second index to a second bucket in the second hash table. In the example method the key and the data value are inserted in one of the first hash table and the second hash table based on the first index and the second index. | 09-18-2008 |
20090259810 | ACCESS CONTROL LIST RULE COMPRESSION USING METER RE-MAPPING - A system may include a content addressable memory (CAM) that is configured to include multiple services, receive a key, where the key includes source port information and IP information related to a packet received on one of multiple ports, and output a match index value in response to a search of the CAM using the key. The system may include a policy memory module that is configured to receive the match index value and to output meter controls and a meter address based on the match index value, a port meter map module that is configured to receive the source port information and to output a mask value and a per port meter value, and a remapping module that is configured to receive the meter address, receive the mask value and the per port meter value, and modify the meter address based on those values. | 10-15-2009 |
20090285095 | TOKEN BUCKET WITH VARIABLE TOKEN VALUE - Various example embodiments are disclosed. According to an example embodiment, a method may include receiving a token count units instruction, periodically increasing or decreasing a token count based at least in part on a refresh rate, and in response to receiving a packet, decreasing or increasing the token count based at least in part on a size of the packet and the instruction. | 11-19-2009 |
20110047439 | SOFT ERROR RATE PROTECTION FOR MEMORIES - Methods and apparatus for performing parity and/or ECC operations are disclosed. An example method includes determining that an opcode is being transmitted on a bus and determining if the transmitted opcode is a memory operation. In the event the transmitted opcode is a memory write operation, the example method includes calculating a parity bit for data associated with the opcode, writing the calculated parity bit to a parity table and writing the data to a memory. The example method also includes, in the event the transmitted opcode is the memory read operation, recovering data from a previously written memory, calculating a parity bit for the recovered data, recovering a previously stored parity bit for the recovered data, comparing the parity bit for the recovered data with the previously stored parity bit and, in the event the recovered data parity bit does not match the previously stored parity bit, providing an error notification. | 02-24-2011 |
Patent application number | Description | Published |
20080213781 | Methods of detecting methylation patterns within a CpG island - A method of increasing sensitivity of a DNA methylation assay by determining complementation within a CpG island of the methylated DNA. | 09-04-2008 |
20080254455 | DETECTING PROSTATE CANCER - Methods and kits for detecting prostate cancer in urine samples include detecting the methylation status of various genes. | 10-16-2008 |
20090047656 | Molecular analysis of primary cells - The present invention provides a method of propagating cells of interest obtained from a biological specimen by a) enriching the cells under conditions that maintain sufficient cell viability; and b) propagating the cells under conditions effective to allow cell viability, proliferation and integrity. | 02-19-2009 |
20090186360 | Detection of GSTP1 hypermethylation in prostate cancer - An assay for detecting prostate cancer includes reagents for detecting multiple methylation markers from within one gene such as GSTP1. | 07-23-2009 |
20100021886 | Methods and Materials for Identifying the Origin of a Carcinoma of Unknown Primary Origin - The present invention provides a method of identifying origin of a metastasis of unknown origin by obtaining a sample containing metastatic cells; measuring Biomarkers associated with at least two different carcinomas; combining the data from the Biomarkers into a linear discrimination analysis where the linear discrimination analysis normalizes the Biomarkers against a reference; and imposes a cut-off which optimizes sensitivity and specificity of each Biomarker, weights the prevalence of the carcinomas and selects a tissue of origin determining origin based on highest probability determined by the linear discrimination analysis or determining that the carcinoma is not derived from a particular set of carcinomas; and optionally measuring Biomarkers specific for one or more additional different carcinoma, and repeating the steps for additional Biomarkers. | 01-28-2010 |
20100041051 | Prostate Cancer Methylation Assay - An assay for diagnosing or prognosticating prostate cancer incorporates the detection of hypermethylation of SEQ ID NO 1, SEQ ID NO 3, and SEQ ID NO 2 genes and may be incorporated into a nomogram. | 02-18-2010 |
20100081145 | Detecting Prostate Cancer - Methods and kits for detecting prostate cancer in urine samples include detecting the methylation status of various genes. | 04-01-2010 |